Smoking is more prevalent in persons living with HIV than the general population and is linked to increased morbidity and mortality. Some have suggested that based on current knowledge of harms and benefits, it may be feasible to advise smokers who are unable or unwilling to quit to switch to electronic cigarettes (ECs) as a less harmful alternative. We conducted 25 qualitative interviews with HIV-positive current or former smokers to explore perceived barriers to smoking cessation and perceptions of ECs. A high level of nicotine dependence, smoking as a form of stress management, motivational factors (including lack of readiness, low self-efficacy, ambivalence toward quitting), and having a social network of smokers were identified as cessation barriers. Low knowledge of ECs and uncertainty about EC safety and efficacy were barriers to EC uptake. However, current smokers indicated a willingness to try ECs. This study provides evidence that HIV-positive smokers face significant individual and environmental barriers to cessation. ECs may have potential as a harm reduction strategy in this population; however, there is a significant need for education regarding use and relative safety.
Introduction
The prevalence of cigarette smoking among PLWH in the U.S. is 3-4 times that of the general population (40-70)% (Lifson & Lando, 2012; Mdodo et al., 2015; Pacek & Cioe, 2015) and recent studies have found that HIV-positive smokers lose more years to smoking than to HIV infection itself (Helleberg et al., 2015; Reddy et al., 2016) . HIV-positive smokers have increased rates of cardiovascular disease, pulmonary disease (Cui et al., 2010; Feinstein et al., 2016; Freiberg et al., 2013; So-Armah & Freiberg, 2014) , and cancer (Helleberg et al., 2014; Reddy et al., 2017) and cigarette smoking is the single greatest contributor to the elevated rate of disease (Glass et al., 2006; Lifson & Lando, 2012) . Smoking cessation studies in PLWH have demonstrated disappointing outcomes (Cioe, 2013; Ledgerwood & Yskes, 2016; Pacek & Cioe, 2015) . Although the majority of HIV-positive smokers report a strong desire to quit (Mamary, Bahrs, & Martinez, 2002) , they are less likely to quit compared with general population smokers (Cooperman, 2016; Mdodo et al., 2015) , and smoking cessation barriers among PLWH needs to be explored (Cooperman, 2016) further. Interest in and use of smoking cessation medications in PLWH is generally low (Ledgerwood & Yskes, 2016; Pacek & Cioe, 2015) and less than half of these smokers endorse total abstinence as a goal (Humfleet et al., 2009; Niaura et al., 2000) . Some studies in PLWH have shown promise in non-cessation smoking-related endpoints, such as reducing the number of cigarettes smoked per day, lowering nicotine dependence levels, and reducing withdrawal symptoms (Cropsey et al., 2013) , which may eventually lead to cessation.
Electronic cigarette (EC) awareness and use have increased over the past 3-5 years (Pericot-Valverde, Gaalema, Priest, & Higgins, 2017) and over one-third of smokers in the general population report that they have tried ECs (King, Patel, Nguyen, & Dube, 2015) . Some studies report that ECs aid in smoking reduction, temporary abstinence (Caponnetto, Polosa, Russo, Leotta, & Campagna, 2011; Polosa et al., 2014; Siegel, Tanwar, & Wood, 2011) , and reduced craving (Bullen et al., 2010) ; however, other studies show that ECs do not increase smoking cessation levels (Bullen et al., 2013; Caponnetto et al., 2013) . Despite this, many smokers perceive ECs to be less harmful than tobacco, and, some EC users believe that ECs will help them achieve smoking cessation (Pericot-Valverde et al., 2017; Soule, Maloney, Guy, Eissenberg, & Fagan, 2017; Stein et al., 2015) . Many smokers reduce their combustible cigarette (CC) smoking when using ECs, which may lead to eventual smoking cessation (Etter & Bullen, 2011 Polosa et al., 2011) .
The long-term effects of ECs are unknown. However, a Cochrane review found that serious adverse events related to short-term EC use were rare (McRobbie, Bullen, Hartmann-Boyce, & Hajek, 2014) . It is thought that, over the long term, switching from CCs to ECs greatly reduces harm to users and those around them (Hajek, Etter, Benowitz, Eissenberg, & McRobbie, 2014; Levy et al., 2018) . Some have suggested that, based on current knowledge, it may be feasible for health care providers to advise smokers who are unable or unwilling to quit to switch to ECs as a less harmful alternative to smoking and a possible route to cessation . The purpose of this study was to examine perceived barriers to smoking cessation and perceptions of ECs among PLWH.
Methods
This study was a qualitative secondary data analysis (Szabo & Strang, 1997) . The parent study (N = 30) examined perceptions of cardiovascular disease (CVD) risk in PLWH. Eligibility criteria, recruitment, data collection, and data analysis procedures have been previously reported (Cioe, Guthrie, Freiberg, Williams, & Kahler, 2018) . We included only current or former cigarette smokers in this analysis. The interviews queried smoking behaviors (current and past), quit attempts, barriers to cessation, and EC perceptions (see Appendix).
Results
Thirty-six patients were screened for the parent study; 25 were eligible for this analysis, with 11 ineligible due to never smoking. Table 1 summarizes the sample demographic and clinical characteristics, obtained by selfreport. Answers to interview questions revealed four themes related to barriers to smoking cessation and three themes related to perceptions of ECs. Illustrative quotes corresponding to each theme are shown in Tables 2 and 3.
Theme 1. A high level of nicotine dependence
Participants described difficulty in quitting smoking, despite a desire to quit and multiple quit attempts. They attributed this difficulty to a high level of dependence on nicotine. Those with illicit drug use histories described the addiction to nicotine as more difficult to address than illicit drugs they had used in the past and explained that this had impeded their ability to stop smoking. They also described having symptoms of nicotine withdrawal and cravings. Some participants stated that they did not have the ability to quit, expressing low self-efficacy for quitting. Further, the participants stated that they were unable to change their smoking habits despite their knowledge that continued smoking would affect their health. Theme 2. The perception that smoking helped manage stress Each participant who indicated that they had made a quit attempt in the past was asked about the factors that led to their slip or relapse. Many participants indicated that they had slipped or relapsed to smoking during a stressful situation and believed that smoking helped them manage stress. They described a lack of alternative stress management skills and explained that cigarette smoking fostered a sense of calm.
Theme 3. Low motivation to quit
Some study participants said that their motivation to quit was low, and they weren't ready to quit. Others expressed ambivalence toward quitting explaining that they enjoyed smoking. Some participants reported that they consciously chose not to quit.
Theme 4. Having a social network of smokers
Participants stated that many of their friends or family members smoked, which was perceived as a barrier to quitting successfully. It also was related to their lack of desire to make an initial quit attempt. Further, participants reported that having smokers in their social networks contributed to their relapse after a quit attempt.
Theme 5. Low level of EC knowledge
Participants described having a lack of information about ECs, with any knowledge of ECs coming from what they had seen on television or had learned from other smokers. There was confusion over the constituents in ECs and whether they contained nicotine. Participants also perceived that ECs were expensive compared to CCs. Theme 6. EC safety and efficacy.
Participants had general safety concerns, especially compared to a CC. Some were worried about EC vapor and long-term health effects. Participants reported knowing smokers who tried ECs and had not quit, so they were not sure they would aid in cessation.
Theme 7. Willingness to try ECs
Most participants indicated a willingness to try ECs. However, because there was concern about the cost of ECs, participants said they would be more willing to try ECs if they were provided as part of a program.
Discussion
This study provides evidence that HIV-positive smokers face significant individual and environmental barriers to smoking cessation, some of which may be especially salient in this population. ECs as a method of harm reduction or path toward cessation may have potential in this population; however, there is a significant need for education regarding their use and relative safety or harm, compared with CCs.
Individual barriers cited, including nicotine dependence, perceived risk of withdrawal, craving, and smoking for stress management, have been previously reported in the literature (Weinberger, Seng, Esan, & Shuter, 2017) . These barriers prevented smokers from achieving abstinence despite knowing that smoking affected their health. Utilizing effective pharmacologic therapy in this group of smokers during quit attempts to reduce these barriers is essential. Previous studies have demonstrated that nicotine replacement therapy (NRT) adherence in this population is poor (Ingersoll, Cropsey, & Heckman, 2009; Ledgerwood & Yskes, 2016; Matthews, Conrad, Kuhns, Vargas, & King, 2013) , therefore research to improve uptake of and adherence to combination NRT or oral medications, such as bupropion and varenicline, are clearly needed (Ledgerwood & Yskes, 2016; Pacek & Cioe, 2015) .
A social network of smokers emerged as an environmental barrier to successful cessation. Inadequate social support for smoking cessation has been previously reported in PLWH (Gamarel et al., 2017; Krishnan et al., 2017) suggesting that interventions to enhance social support are needed. A pilot study using peer counselors with NRT noted significant differences in 7-day point prevalence abstinence, suggesting that enhancing social support may be an effective approach (Wewers, Neidig, & Kihm, 2000) . A cell-phone intervention that aimed to enhance social support was also promising (Vidrine, Marks, Arduino, & Gritz, 2012) . Standard approaches are not adequate for HIV-positive smokers, and targeted, innovative approaches are needed to improve outcomes.
Finally, participants had low EC knowledge. Yet, despite a concern for safety (compared with CC), participants expressed a willingness to try them. Similarly, a study in opioid-dependent smokers reported that 80% of participants were willing to try ECs (Stein et al., 2015) . Our findings directly contrast EC safety perceptions in the general population, however, where it has been reported that most smokers believe that ECs were not at all or less harmful than CCs (Pericot-Valverde et al., 2017; Stein et al., 2015) . There is a need for education regarding the substantial harm of continued CC smoking, and the comparative or relative safety of ECs in PLWH. One study examined positive outcome expectancies related to EC use among general population smokers, recognizing that this may be an important Table 3 . Illustrative quotes of electronic cigarettes perceptions. I don't know anything about "em. It" s just differentit's different … I don't know. It's just like a vapor that comes out of it. And itit gives a differentsome of "em have vanilla or chocolate, or it just gives different sense of smells. (52 year old female) Um, you"re off of nicotine, you know. And that's whatuh, that wouldthat would attract me to it. … they're kind of expensive … they really are. I had a friend of mine, paid $100.00 for one. They are expensive. They last a pretty long time. But, I just can't afford that. (50 year old male) [I know] nothing [about ECs] , other than what they say on TV. I don't know how much they cost. I'd have to find out how much they cost and how long it, likeyou know, how long do they last before you have to replace them and everything. (72 year old female) I really don't know anything about them. They deliver nicotine? I'm not as big a fan of something that's gonna give me the drug that I'm hooked on. I know people who have. Well, some of them like it, and they haven't gone back to real cigarettes, but they'rethey're hooked on that electronic thing. (50 year old male) Theme 6. EC Safety and efficacy. I don't bother with "em … I even hate it when, like, they do it in the buildin" … it fills up with all this vapor and stuff like that … I don't know (if they're safer than a cigarette).
(52 year old female) I've had several people that are on it, and they're right back to smoking, so … they were just using the electronic cigarette. And then they just went back to cigarettes … . (50 year old male) But they're so new out, I guarantee 10, 15 years down the road, there's gonna be some kind of reaction from doing these vapors … It's only a matter of time construct related to EC uptake (Soule et al., 2017) . They found that ECs provided users with similar positive effects as CCs, such as perceived stress reduction and increased relaxation. Research is needed to determine whether a similar effect is noted among HIV-positive smokers. Concern for cost of ECs was reported, however, with the current cost of CCs, ECs may be similar in cost as this point.
This study has some limitations. As a qualitative study, results may not generalize to all HIV-positive smokers. Also, the primary study examined CVD risk perception and did not collect data on current EC use. Notwithstanding this limitation, this study has important strengths. It is, to our knowledge, the first study to qualitatively examine barriers to smoking cessation and perceptions of electronic cigarettes in PLWH, a group that is disproportionally affected by smoking-related morbidity and mortality. Secondly, this study enrolled both current and former CC smokers, increasing the range of perceptions and responses from both those who have been unable or unwilling to quit, and those who have successfully achieved sustained abstinence.
In summary, HIV-positive smokers face individual and environmental barriers to smoking cessation. Improved understanding of the perceived barriers to smoking cessation among HIV-positive smokers may inform the development of innovative strategies for this population. While the long-term effects of ECs are unknown (McNeill et al., 2015) , they may represent a less harmful option for smokers who are highly dependent on nicotine and are unwilling or unable to quit smoking. However, education regarding potential benefits or harms of ECs in PLWH is needed.
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